Salarius Pharmaceuticals announces 1-for-15 reverse stock split to regain Nasdaq compliance

1 hour ago 1

Salarius Pharmaceuticals (NASDAQ:SLRX) will implement a 1-for-15 reverse stock split effective August 15, 2025.
The split aims to meet Nasdaq’s $1 minimum bid price requirement for continued listing.
Outstanding shares will be reduced from ~7.6M to ~509,000.
Source: Press release

Recommended For You